Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Herbal combination (Boswellia, turmeric, grape extract) for hip or knee osteoarthritis

Official title: Effectiveness of a Herbal Supplement Containing Boswellia Serrata, Curcuma Longa, and Vitis Vinifera in Patients With Osteoarthritis.

Run by Middlesex University · NCT07324746 · Data updated 2026-11-12

This study will test whether a daily herbal supplement containing Boswellia serrata, turmeric (curcumin), and grape extract (Vitis vinifera) reduces pain and improves function in adults with hip or knee osteoarthritis.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorMiddlesex University
Academic / other
Locations1 site (London)
StatusRecruiting
StartedDecember 5, 2025
Main results expectedSeptember 2026
Study endsSeptember 2026
Registry record updatedJanuary 29, 2026
Trial IDNCT07324746 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 and over with clinically diagnosed knee or hip osteoarthritis, moderate pain (NRS ≥4) and a Lequesne Functional Index ≥7 who can attend the London site and complete online assessments.

Probably not a fit

People who are pregnant or breastfeeding, have autoimmune joint disease, recent intra-articular or systemic corticosteroid use, severe joint injury or complete cartilage loss, significant liver or kidney dysfunction, or known allergy to the supplement ingredients are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, placebo-controlled crossover trial in which adults with clinically diagnosed hip or knee osteoarthritis will take the active herbal supplement for four weeks and a matching placebo for four weeks, one after the other. Participants will complete validated symptom questionnaires and three performance-based physical tests six times in total and will provide a urine sample for safety or compliance checks. Eligible participants must have moderate pain (NRS ≥4) and functional impairment (Lequesne Index ≥7); people with autoimmune disease, recent steroid injections, severe joint damage, pregnancy, or abnormal liver/kidney function are excluded. The primary comparison is symptom change between the supplement and placebo periods.

Why it matters

Potential benefit: If effective, the herbal combination could reduce pain and improve mobility for people with knee or hip osteoarthritis, offering a non-prescription alternative to standard pain medications.

How similar studies have gone: Multiple small randomized trials and meta-analyses have reported modest symptom improvements with curcumin and Boswellia formulations in osteoarthritis, but larger, rigorously controlled studies are still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged ≥ 18
* Diagnosis of osteoarthritis in knee or hip
* Numerical Rating Scale (NRS) ≥ 4 during the most painful movement in the last 24 hours
* Lequesne's Functional Index (LFI) score ≥ 7
* Ambulant patient

Exclusion Criteria:

* Pregnant and breastfeeding
* Autoimmune disease such as rheumatoid arthritis, gout, lupus
* Joint trauma, joint injury, joint infection, meniscus tear, complete loss of articular cartilage
* Expectation of surgery
* History of the viscous or corticosteroids injections into affected joints or oral corticosteroids within last 12 months
* Allergy to one of the intervention's ingredients or NSAIDs
* Peptic ulceration and upper gastrointestinal haemorrhage
* High alcohol intake, inability to abstain from alcohol, substance abuse, history of addiction
* Tumor, cancer
* Abnormal renal or/and hepatic functions or altered blood chemistry
* Use of concomitant medication able to interfere with the interventions

Where it's running

  • Middlesex Univeristy London
    London, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.